Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Exposure related observations in humans: other data

Currently viewing:

Administrative data

Endpoint:
exposure-related observations in humans: other data
Type of information:
other: case report
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Basic data given

Data source

Reference
Reference Type:
publication
Title:
In vitro demonstartion of specific IgE in phthalic anhydride hypersensitivity
Author:
Maccia CA, Bernstein IL, Emmett EA, Brook SM
Year:
1976
Bibliographic source:
Am. Rev. Respir. Dis. 113, 701-704.

Materials and methods

Type of study / information:
Type of experience: other: Biological monitoring at the workplace
Endpoint addressed:
repeated dose toxicity: inhalation
Principles of method if other than guideline:
A 38-year old chemical foreman noted symptoms of rhinorrhea, postnasal drip, and wheezing several months after he was transferred to a plant which phthalic anhydride (PA) was used as a reagent
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Phthalic anhydride
EC Number:
201-607-5
EC Name:
Phthalic anhydride
Cas Number:
85-44-9
Molecular formula:
C8H4O3
IUPAC Name:
1,3-dihydro-2-benzofuran-1,3-dione

Method

Details on study design:
Physical examination, skin tests, radioimmuno assay, bronchial challenge tests were performed
Exposure assessment:
not specified

Results and discussion

Results:
Phthalic anhydride specific immunoglobin E (IgE) was detected by a radio-allergosorbent test (RAST) in the serum of a chemical worker with hypersensitivity to phthalic anhydride

Any other information on results incl. tables

Positive skin tests, provocative bronchial challenges, and a high serum titer of specific IgE to phthalic anhydride corroborated his clinical hypersensitivity.

Applicant's summary and conclusion

Executive summary:

A 38-year old chemical foreman noted symptoms of rhinorrhea, postnasal drip, and wheezing several months after he was transferred to a plant which phthalic anhydride (PA) was used as a reagent.

Positive skin tests, provocative bronchial challenges, and a high serum titer of specific IgE to phthalic anhydride corroborated his clinical hypersensitivity.